- Home
- XXII vs GCTK Comparison
XXII vs GCTK Comparison
Compare XXII & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XXII | GCTK |
|---|---|---|
| Founded | 1998 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3M | 3.0M |
| IPO Year | 2011 | 2011 |
Fundamental Metrics
Financial Performance| Metric | XXII | GCTK |
|---|---|---|
| Price | $4.40 | $0.40 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 21.1K | ★ 481.0K |
| Earning Date | 05-12-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 69.96 | N/A |
| EPS | N/A | ★ 2.65 |
| Revenue | ★ $25,832,530.00 | $589,462.00 |
| Revenue This Year | $370.28 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.16 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.27 | $0.29 |
| 52 Week High | $11.37 | $14.14 |
Technical Indicators
Market Signals| Indicator | XXII | GCTK |
|---|---|---|
| Relative Strength Index (RSI) | 58.48 | 49.23 |
| Support Level | $3.68 | $0.29 |
| Resistance Level | $6.86 | $0.73 |
| Average True Range (ATR) | 0.35 | 0.04 |
| MACD | -0.13 | 0.02 |
| Stochastic Oscillator | 39.75 | 84.10 |
Price Performance
Historical ComparisonAbout XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.
About GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.